https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-03-04 / Radiother Oncol 2008 Mar;86(3):435-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-03-04 / Radiother Oncol 2008 Mar;86(3):435-422008-03-04 00:00:002019-02-15 08:59:43Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-03-04 / J. Neuroimmunol. 2008 Mar;195(1-2):21-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-03-04 / J. Neuroimmunol. 2008 Mar;195(1-2):21-72008-03-04 00:00:002019-02-15 09:22:04Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-03-01 / Bull Cancer 2008 Mar;95(3):320-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-03-01 / Bull Cancer 2008 Mar;95(3):320-62008-03-01 00:00:002019-02-15 08:51:24Immunotherapy of hematological malignancies using dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-03-01 / Int J Hyperthermia 2008 Mar;24(2):171-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-03-01 / Int J Hyperthermia 2008 Mar;24(2):171-812008-03-01 00:00:002008-03-01 00:00:00The importance of schedule in whole body thermochemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-26 / J. Cancer Res. Clin. Oncol. 2008 Sep;134(9):987-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-26 / J. Cancer Res. Clin. Oncol. 2008 Sep;134(9):987-942008-02-26 00:00:002019-02-15 09:19:23Dendritic cell based genetic immunization stimulates potent tumor protection dependent on CD8 CTL cells in the absence of autoimmunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-15 / Biochim. Biophys. Acta 2008 Apr;1785(2):217-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-15 / Biochim. Biophys. Acta 2008 Apr;1785(2):217-312008-02-15 00:00:002019-02-15 09:22:03Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-13 / Cancer Immunol. Immunother. 2008 Sep;57(9):1421-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-13 / Cancer Immunol. Immunother. 2008 Sep;57(9):1421-72008-02-13 00:00:002021-11-15 17:05:45Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-08 / Crit. Rev. Oncol. Hematol. 2008 May;66(2):118-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-08 / Crit. Rev. Oncol. Hematol. 2008 May;66(2):118-342008-02-08 00:00:002019-02-15 08:49:32Dendritic cell vaccines in melanoma: from promise to proof?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-05 / Br. J. Cancer 2008 Feb;98(4):784-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-05 / Br. J. Cancer 2008 Feb;98(4):784-912008-02-05 00:00:002008-02-05 00:00:00Immunisation with ’naïve‘ syngeneic dendritic cells protects mice from tumour challenge
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Expert Rev Anticancer Ther 2008 Feb;8(2):243-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Expert Rev Anticancer Ther 2008 Feb;8(2):243-572008-02-01 00:00:002019-02-15 08:52:23Immunotherapy opportunities in ovarian cancer
